Medicare proposes covering expensive Alzheimer's drug for those in clinical trials
Aduhelm is the first treatment approved in the country to slow cognitive decline in those living with Alzheimer's. Doctors have refused to prescribe it, given the lack of data and evidence behind it.
Read more on NPR
Thứ Tư, 12 tháng 1, 2022
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét